Skip to main content
. 2024 Dec 20;24:1559. doi: 10.1186/s12885-024-13354-8

Table 1.

Patients’ characteristics

Training set Validation set P
Items n = 501 n = 1533
Age (years), mean (SD) 48.63(9.41) 49.01(9.51) 0.439
BMI (Kg/m2), mean (SD) 25.23(4.87) 24.05(5.06) 0.534
Menopause, n (%) 0.550
Yes 276(55.1) 821(53.6)
No 225(44.9) 712(46.4)
Family history, n (%) 0.737
Yes 37(7.4) 142(9.3)
No 464(92.6) 1391(90.7)
Blood type, n (%) 0.981
A 117(23.4) 361(23.5)
B 164(32.7) 495(32.3)
AB 63(12.6) 185(12.1)
O 157(31.3) 492(32.1)
Tumor site, n (%) 0.387
Right 233(46.5) 679(44.3)
Left 268(53.5) 854(55.7)
LNP, n (%) 0.800
Positive 326(65.1) 1007(65.7)
Negative 175(34.9) 526(34.3)
Tumor size, n (%) 0.093
< 30 mm 181(36.1) 614(40.1)
30–50 mm 219(43.7) 637(41.6)
> 50 mm 101(20.2) 282(18.4)
Histological Grading, n (%) 0.614
Grade I 110(22.0) 296(19.3)
Grade II 333(66.5) 1080(70.5)
Grade III 58(11.5) 157(10.2)
TNM stage, n (%) 0.614
II 265(52.9) 771(50.3)
III 236(47.1) 762(49.7)

SD: standard deviation; BMI: body mass index; LNP: lymph node positivity